Design, synthesis and preliminary activity evaluation of novel L-lysine derivatives as aminopeptidase N/CD13 inhibitors

Protein and Peptide Letters

Volumn 17, Issue 7, 2010, Pages 847-853

  Wang, Qiang ^a,b   Xu, Fuming ^a   Mou, Jiajia ^a   Zhang, Jian ^a   Shang, Luqing ^c   Luan, Yepeng ^a   Yuan, Yumei ^a   Liu, Yingzi ^a   Li, Minyong ^a   Fang, Hao ^a   Wang, Binghe ^d   Xu, Wenfang ^a  

^a SHANDONG UNIVERSITY   (China)

^b SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^c NANKAI UNIVERSITY   (China)

^d GEORGIA STATE UNIVERSITY   (United States)

Author keywords

APN; Inhibitor; Lysine derivatives; Synthesis

Indexed keywords

ANTINEOPLASTIC AGENT; BESTATIN; DRUG DERIVATIVE; ENZYME INHIBITOR; LEUCINE; LYSINE; MICROSOMAL AMINOPEPTIDASE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; ENZYME ACTIVE SITE; HUMAN; METABOLISM; SYNTHESIS; TUMOR CELL LINE; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS;

ANTIGENS, CD13; ANTINEOPLASTIC AGENTS; CATALYTIC DOMAIN; CELL LINE, TUMOR; ENZYME INHIBITORS; HUMANS; LEUCINE; LYSINE; MODELS, MOLECULAR;

EID: 77954721973     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610791306661     Document Type: Article

References (25)

1. Joong, S.S.; Jin, H.K.; Hyun, Y.C.; Young, N.Y.; Seung, H.K.; Hyun, J.P.; Bum, S.S.; Seung, H.C. Irreversible Inhibition of CD13/Aminopeptidase N by the Antiangiogenic Agent Curcumin. Chem. Biol., 2003, 10, 695-704.
2. Dixon, J.; Kaklamanis, L.; Turley, H.; Hickson, I. D.; Leek, R. D.; Harris, A. L.; Gatter, K. C. Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J. Clin. Pathol., 1994, 47(1), 43.
3. Sato, Y. Biol. Role of Aminopeptidase in Angiogenesis. Pharm. Bull., 2004, 27(6), 772.
4. Bedir, A.; Ozener, I. C.; Emerk, K. Urinary leucine aminopeptidase is a more sensitive indicator of early renal damage in non-insulin- dependent diabetics than microalbuminuria. Nephron., 1996, 74(1), 110-3.
5. Sloane, P. D.; Zimmerman, S.; Suchindran, C.; Reed, P.; Wang, L.; Boustani, M.; Sudha, S. THE PUBLIC HEALTH IMPACT OF ALZHEIMER'S DISEASE: potential implication of treatment advances Annu. Rev. Public Health, 2002, 23, 213-231.
6. Xu, W. F.; Li, Q. B. Progress in the development of aminopeptidase N (APN/CD13) inhibitors. Curr. Med. Chem. Anti-Cancer Agents, 2005, 5(3), 281-301.
7. Umezawa, H.; Aoyagi, T.; Suda, H.; Hamada, M. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot., 1976, 29(1), 97-99.
8. Aoyagi, T.; Yoshida, S.; Nakamura, Y.; Shigihara, Y. Probestin, a new inhibitor of aminopeptidase M, produced by Streptomyces azureus MH663-2F6. I. Taxonomy, production, isolation, physicochemical properties and biological activities. J Antibiot., 1990, 43(2), 143-8.
9. Rich, D.H.; Moon, B.J.; Harbeson, S. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes. J. Med. Chem., 1984, 27(4), 417.
10. Umezawa, H.; Aoyagi, T.; Tanaka, T.; Suda, H. Production of actinonin, an inhibitor of aminopeptidase M, by actinomycetes. J Antibiot., 1985, 38(11), 1629-1630.
11. Nagai, M.; Kojima, F.; Naganawa, H. Phebestin, a new inhibitor of aminopeptidase N, produced by Streptomyces sp. MJ716-m3. J Antibiot., 1997, 50(1), 82-4.
12. Lampret, B.R.; Kidric, J.; Kralj, B. Lapstatin, a new aminopeptidase inhibitor produced by Streptomyces rimosus, inhibits autogenous aminopeptidases. Arch. Microbiol., 1999, 171(6), 397-404.
13. Chung, M. C.; Lee, H. J.; Chun, H. K. Bestatin Analogue from Streptomyces neyagawaensis SL-387. Biosci. Biotechnol. Biochem., 1996, 60(5), 898-900.
14. Aoyagi, T.; Yoshida, S.; Matsuda, N. LEUHISTIN, A NEW INHIBITOR OF AMINOPEPTIDASE M, PRODUCED BY Bacillus laterosporus BMI156-14F1. J Antibiot. (Tokyo), 1991, 44(6), 573-578.
15. Egan, M.E.; Pearson, M.; Weiner, S.A. Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects. Science, 2004, 304(5670), 600-602.
16. Shin, J.S.; Lee, H.; Shin, J. Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro. Cancer Lett., 2004, 203(2), 163-169.
17. Li, Q. B.; Fang, H.; Xu, W. F. Novel 3-galloylamido-N'- substituted-2,6-piperidinedione- N- acetamide peptidomimetics as metalloproteinase inhibitors. Bioorg. Med. Chem. Lett., 2007, 17(10), 2935-8.
18. Wang, J. L.; Xu, W. F. The preparation of novel L-iso-glutamine derivatives as potential antitumor agents. J. Chem. Res. Synop., 2003, 12, 789-791.
19. Shang, L. Q.; Maeda, T.; Xu, W. F.; Kishioka, S. Evaluation of a novel aminopeptidase N inhibitor, in vitro, using two assay systems. J Enzyme Inhib. Med. Chem., 2008, 23(2), 198-205.
20. Mou, J. J.; Fang H.; Jing, F. B.; Wang, Q.; Liu, y. Z.; Zhu, H. W.; Shang, L. Q.; Wang, X. J.; Xu, W. F. Design, synthesis and primary activity evaluation of L-arginine derivatives as aminopeptidase N/CD13 inhibitors. Bioorg. Med. Chem., 2009, 17(13), 4666-73.
21. Kiyoshi, I.; Yoshitaka, N.; Yuko, O.; Masahide, T.; Kanako, N.; Futoshi, M.; Takashi, I.; Tadashi, Y. Crystal Structure of Aminopeptidase N (Proteobacteria Alanyl Aminopeptidase) from Escherichia coli and Conformational Change of Methionine 260 Involved in Substrate Recognition. J. Biol. Chem., 2006, 281, 33664-33676.
22. Addlagatta, A.; Gay, L.; Matthews, B.W. Structural Basis for the Unusual Specificity of Escherichia coli Aminopeptidase N. Biochemistry, 2008, 47(19), 5303.
23. Yang, K. H.; Wang, Q.; Su, L.; Fang, H.; Wang, X. J.; Gong, J. Z.; Wang, B. H.; Xu, W. F. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors. Bioorg. Med. Chem., 2009, 17(11), 3810-7.
24. Shang, L. Q.; Fang H.; Zhu, H. W.; Wang, X. J.; Wang, Q.; Mou, J. J.; Wang, B. H.; Kishioka, S.; Xu, W. F. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3- phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors. Bioorg. Med. Chem., 2009, 17(7), 2775-84.
25. Hooper, N. M. Families of zinc metalloproteases. FEBS Lett., 1994, 354(1), 1-6.